Hanseatic Management Services’s Evolent Health EVH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-32,236
Closed -$892K 157
2021
Q4
$892K Buy
32,236
+878
+3% +$25.2K 1.46% 14
2021
Q3
$972K Buy
31,358
+2,280
+8% +$54.7K 1.69% 10
2021
Q2
$614K Buy
29,078
+985
+4% +$19.7K 1.16% 24
2021
Q1
$567K Buy
28,093
+815
+3% +$15.5K 1.13% 21
2020
Q4
$437K Buy
27,278
+1,290
+5% +$17.1K 0.94% 33
2020
Q3
$323K Buy
+25,988
New +$306K 0.73% 37
2019
Q1
Sell
-9,553
Closed -$191K 276
2018
Q4
$191K Buy
9,553
+2
+0% +$46 0.26% 94
2018
Q3
$271K Buy
+9,551
New +$228K 0.25% 101

Other funds holding EVH

Hanseatic Management Services's EVH Position: Q1 2022 in Review

Hanseatic Management Services sold out of Evolent Health (EVH) in Q1 2022, closing a stake of 32,236 shares — an estimated $892K sold.

Hanseatic Management Services first reported a position in EVH in Q3 2018 and held it in 8 quarters. The position peaked at $972K in Q3 2021. 218 funds tracked by Wall St. Rank hold EVH as of Q1 2022.

  • Hanseatic Management Services reported no remaining Evolent Health position as of Q1 2022 after selling out during the quarter.
  • Hanseatic Management Services sold 32,236 Evolent Health shares in Q1 2022, an estimated $892K.
  • Hanseatic Management Services first reported a position in Evolent Health in Q3 2018 and held it in 8 quarters.
  • Hanseatic Management Services's Evolent Health position peaked at $972K in Q3 2021.
  • 218 funds tracked by Wall St. Rank held Evolent Health as of Q1 2022.

Based on Hanseatic Management Services's 13F filing for Q1 2022, filed 29 Apr 2022.